Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Hamps BioBOM:544312 -2.17%13 Days Payable is 51.65 as of Mar. 2026, which is 14% below its 10-year median of 60.36. GuruFocus rates BOM:544312 with a GF Score™ of 13/100. The stock has 4 warning signs investors should review. Among 608 Healthcare Providers & Services companies, Hamps Bio ranks better than 50% on this metric.
Hamps Bio's average Accounts Payable for the
six
months ended in Mar. 2026 was ₹4.53 Mil. Hamps Bio's Cost of Goods Sold for the
six
months ended in Mar. 2026 was ₹16.01 Mil.
Hence, Hamps Bio's Days Payable for the
six
months ended in Mar. 2026 was 51.65.
The historical rank and industry rank for Hamps Bio's Days Payable or its related term are showing as below:
BOM:544312'
s Days Payable Range Over the Past 10 Years
Min: 53.05 Med: 60.36 Max: 80.26
Current: 58
During the past 5 years, Hamps Bio's highest Days Payable was 80.26. The lowest was 53.05. And the median was 60.36.
BOM:544312's Days Payable is ranked better than 50% of 608
companies
in the Healthcare Providers & Services industry
Industry Median: 57.74
vs BOM:544312: 58.00
Hamps Bio's Days Payable
declined
from Mar. 2025 (128.42) to Mar. 2026 (51.65).
It may suggest that Hamps Bioaccelerated paying its suppliers.
The historical data trend for Hamps Bio's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Hamps Bio's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hamps Bio Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Hamps Bio's Days Payable distribution charts can be found below:
* The bar in red indicates where Hamps Bio's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Hamps Bio's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hamps Bio (BOM:544312) has a Days Payable of 51.65 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Hamps Bio and its competitors. This is 14% below median its historical median of 60.36. Over the past decade, Hamps Bio's Days Payable has ranged from 53.05 to 80.26. According to the industry distribution chart, Hamps Bio ranks #304 out of 608 companies in the Healthcare Providers & Services industry, placing it in the top 50%.
Is Hamps Bio's Days Payable too high?
Hamps Bio's current Days Payable of 51.65 is 14% below median its 10-year median of 60.36. Over the past 10 years, this metric has ranged from a low of 53.05 to a high of 80.26. The Healthcare Providers & Services industry median Days Payable is 57.74. Hamps Bio's value of 51.65 is 10.5% below this industry median. Based on the distribution chart, Hamps Bio ranks #304 out of 608 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Hamps Bio has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Hamps Bio's Days Payable compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Hamps Bio ranks #304 out of 608 companies for Days Payable. This puts Hamps Bio in the upper half of its industry. The industry median Days Payable is 57.74. Hamps Bio's value of 51.65 is 10.5% below this benchmark. Historically, Hamps Bio's own Days Payable has ranged from 53.05 to 80.26 over the past decade. While the company's 10-year median is 60.36 vs. the industry median of 57.74, Hamps Bio has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 57.74, based on 608 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hamps Bio's current Days Payable of 51.65 is 10.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Hamps Bio and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 57.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hamps Bio's current Days Payable is 51.65, which is 14% below median its own 10-year median of 60.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hamps Bio stock overvalued right now?
Hamps Bio (BOM:544312) has a current Days Payable of 51.65. The current Days Payable is 51.65, which is 14% below median its 10-year median of 60.36 and 10.5% below the Healthcare Providers & Services industry median of 57.74. Hamps Bio's overall GF Score™ is 13/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Hamps Bio (BOM:544312), the current Days Payable is 51.65 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Hamps Bio Ltd is engaged in the ethical marketing and distribution of pharmaceutical formulation products. Its product include tablets, syrups, capsules, injectables, oil, gel and powder used as medicine and nutrition supplements as well as the manufacturing of freeze dried and frozen products such as fruits, vegetables, herbs and flowers. The company segment includes Manufacturing, trading and distribution of Pharmaceutical formulation products and Manufacturing of Freeze dried and frozen products like fruits, vegetables, herbs, flowers, etc. Key revenue is generated from Medicine Products.
13GF Score
Get the complete analysis for BOM:544312
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544312 has been successfully added to your 
